Mas receptor deficiency exacerbates lipopolysaccharide-induced cerebral and systemic inflammation in mice

Immunobiology

Volumn 220, Issue 12, 2015, Pages 1311-1321

  Oliveira Lima, Onésia C ^a   Pinto, Mauro C X ^a   Duchene, Johan ^b   Qadri, Fatimunnisa ^b   Souza, Laura L ^a,c   Alenina, Natalia ^a,b   Bader, Michael ^a,b   Santos, Robson A S ^a   Carvalho Tavares, Juliana ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c IEP Instituto Sírio Libanês de Ensino e Pesquisa   (Brazil)

Author keywords

Inflammation; Lipopolysaccharide; Mas receptor; Renin angiotensin system

Indexed keywords

CD11B ANTIGEN; G PROTEIN COUPLED RECEPTOR; INTERLEUKIN 10; MAS RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; CHEMOKINE; CYTOKINE; LIPOPOLYSACCHARIDE; ONCOPROTEIN; PROTO-ONCOGENE PROTEINS C-MAS-1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; BRAIN LEVEL; BRAIN MICROCIRCULATION; CELL INTERACTION; CELL POPULATION; CONTROLLED STUDY; ENCEPHALITIS; GENE DELETION; LEUKOCYTE ADHERENCE; LEUKOCYTE COUNT; MALE; MICROVASCULATURE; MONOCYTE; MOUSE; NEUTROPHIL COUNT; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; ANIMAL; BLOOD; BODY TEMPERATURE; BODY WEIGHT; BONE MARROW; BRAIN; BRAIN CIRCULATION; DEFICIENCY; DISEASE COURSE; DISEASE MODEL; GENETICS; IMMUNOLOGY; INFLAMMATION; KNOCKOUT MOUSE; METABOLISM; MICROCIRCULATION; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; VASCULARIZATION;

ANIMALS; ANTIGENS, CD11B; BIOMARKERS; BODY TEMPERATURE; BODY WEIGHT; BONE MARROW; BRAIN; CEREBROVASCULAR CIRCULATION; CHEMOKINES; CHEMOTAXIS, LEUKOCYTE; CYTOKINES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; INFLAMMATION; LEUKOCYTE COUNT; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, KNOCKOUT; MICROCIRCULATION; MONOCYTES; NEUTROPHILS; PROTO-ONCOGENE PROTEINS; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84942824038     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2015.07.013     Document Type: Article

References (71)

1. Alenina N., Xu P., Rentzsch B., Patkin E.L., Bader M. Genetically altered animal models for Mas and angiotensin-(1-7). Exp. Physiol. 2008, 93:528-537.
2. Alvarez A., Cerda-Nicolas M., Naim Abu Nabah Y., Mata M., Issekutz A.C., Panes J., Lobb R.R., Sanz M.J. Direct evidence of leukocyte adhesion in arterioles by angiotensin II. Blood 2004, 104:402-408.
3. Andonegui G., Goyert S.M., Kubes P. Lipopolysaccharide-induced leukocyte-endothelial cell interactions: a role for CD14 versus toll-like receptor 4 within microvessels. J. Immunol. 2002, 169:2111-2119.
4. Arnaout M.A. Structure and function of the leukocyte adhesion molecules CD11/CD18. Blood 1990, 75:1037-1050.
5. Blanque R., Meakin C., Millet S., Gardner C.R. Hypothermia as an indicator of the acute effects of lipopolysaccharides: comparison with serum levels of IL1 beta, IL6 and TNF alpha. Gen. Pharmacol. 1996, 27:973-977.
6. Buttini M., Limonta S., Boddeke H.W. Peripheral administration of lipopolysaccharide induces activation of microglial cells in rat brain. Neurochem. Int. 1996, 29:25-35.
7. Carey R.M., Siragy H.M. Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation. Endocr. Rev. 2003, 24:261-271.
8. Cauwels A., Buys E.S., Thoonen R., Geary L., Delanghe J., Shiva S., Brouckaert P. Nitrite protects against morbidity and mortality associated with TNF-α or LPS-induced shock in a soluble guanylate cyclase-dependent manner. J. Exp. Med. 2009, 206:2915-2924.
9. Carvalho-Tavares J., Fox-Robichaud A., Kubes P. Assessment of the mechanism of juxtacrine activation and adhesion of leukocytes in liver microcirculation. Am. J. Physiol. 1999, 276:828-834.
10. D'Mello C., Le T., Swain M.G. Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factoralpha signaling during peripheral organ inflammation. J. Neurosci. 2009, 29:2089-2102.
11. da Silveira K.D., Coelho F.M., Vieira A.T., Sachs D., Barroso L.C., Costa V.V., Bretas T.L., Bader M., de Sousa L.P., da Silva T.A., dos Santos R.A., Simoes e Silva A.C., Teixeira M.M. Anti-inflammatory effects of the activation of the angiotensin-(1-7) receptor, MAS, in experimental models of arthritis. J. Immunol. 2010, 185:5569-5576.
12. Donoghue M., Hsieh F., Baronas E., Godbout K., Gosselin M., Stagliano N., Donovan M., Woolf B., Robison K., Jeyaseelan R., Breitbart R.E., Acton S. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ. Res. 2000, 87:1-9.
13. Duvernoy H.M., Risold P.Y. The circumventricular organs: an atlas of comparative anatomy and vascularization. Brain Res. Rev. 2007, 56:119-147.
14. El-Hashim A.Z., Renno W.M., Raghupathy R., Abduo H.T., Akhtar S., Benter I.F. Angiotensin-(1-7) inhibits allergic inflammation, via the MAS1 receptor, through suppression of ERK1/2- and NF-kappaB-dependent pathways. Br. J. Pharmacol. 2012, 166:1964-1976.
15. Fagerholm S.C., Varis M., Stefanidakis M., Hilden T.J., Gahmberg C.G. Alpha-chain phosphorylation of the human leukocyte CD11b/CD18 (Mac-1) integrin is pivotal for integrin activation to bind ICAMs and leukocyte extravasation. Blood 2006, 108:3379-3386.
16. Freund M., Walther T., von Bohlen und Halbach O. Immunohistochemical localization of the angiotensin-(1-7) receptor Mas in the murine forebrain. Cell Tissue Res. 2012, 348:29-35.
17. Furze R.C., Rankin S.M. Neutrophil mobilization and clearance in the bone marrow. Immunology 2008, 125:281-288.
18. Grutz G. New insights into the molecular mechanism of interleukin-10-mediated immunosuppression. J. Leukoc. Biol. 2005, 77:3-15.
19. Habicht G.S. Body temperature in normal and endotoxin-treated mice of different ages. Mech. Ageing Dev. 1981, 16:97-104.
20. Hawiger J. Innate immunity and inflammation: a transcriptional paradigm. Immunol. Res. 2001, 23:99-109.
21. Hoch N.E., Guzik T.J., Chen W., Deans T., Maalouf S.A., Gratze P., Weyand C., Harrison D.G. Regulation of T-cell function by endogenously produced angiotensin II. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 296:208-216.
22. Jerke U., Rolle S., Purfurst B., Luft F.C., Nauseef W.M., Kettritz R. Beta2 integrin-mediated cell-cell contact transfers active myeloperoxidase from neutrophils to endothelial cells. J. Biol. Chem. 2013, 288:12910-12919.
23. Jiang T., Gao L., Guo J., Lu J., Wang Y., Zhang Y. Suppressing inflammation by inhibiting the NF-kappaB pathway contributes to the neuroprotective effect of angiotensin-(1-7) in rats with permanent cerebral ischaemia. Br. J. Pharmacol. 2012, 167:1520-1532.
24. Keidar S., Kaplan M., Gamliel-Lazarovich A. ACE2 of the heart: from angiotensin I to angiotensin (1-7). Cardiovasc. Res. 2007, 73:463-469.
25. Kobayashi Y. The role of chemokines in neutrophil biology. Front. Biosci. 2008, 13:2400-2407.
26. Lefort J., Singer M., Leduc D., Renesto P., Nahori M.A., Huerre M., Creminon C., Chignard M., Vargaftig B.B. Systemic administration of endotoxin induces bronchopulmonary hyperreactivity dissociated from TNF-alpha formation and neutrophil sequestration into the murine lungs. J. Immunol. 1998, 161:474-480.
27. Ley K., Laudanna C., Cybulsky M.I., Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 2007, 7:678-689.
28. Luscinskas F.W., Brock A.F., Arnaout M.A., Gimbrone M.A. Endothelial-leukocyte adhesion molecule-1-dependent and leukocyte (CD11/CD18)-dependent mechanisms contribute to polymorphonuclear leukocyte adhesion to cytokine-activated human vascular endothelium. J. Immunol. 1989, 142:2257-2263.
29. Magalhaes G.S., Rodrigues-Machado M.G., Motta-Santos D., Silva A.R., Caliari M.V., Prata L.O., Abreu S.C., Rocco P.R., Barcelos L.S., Santos R.A., Campagnole-Santos M.J. Angiotensin-(1-7) attenuates airway remodeling and hyperresponsiveness in a model of chronic allergic lung inflammation. Br. J. Pharmacol. 2015, 172:2330-2342.
30. Maier S.F., Watkins L.R. Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol. Rev. 1998, 105:83-107.
31. Marik P.E., Zaloga G.P. Hypothermia and cytokines in septic shock. Norasept II study investigators. North American study of the safety and efficacy of murine monoclonal antibody to tumor necrosis factor for the treatment of septic shock. Intensive Care Med. 2000, 26:716-721.
32. Masocha W. Systemic lipopolysaccharide (LPS)-induced microglial activation results in different temporal reduction of CD200 and CD200 receptor gene expression in the brain. J. Neuroimmunol. 2009, 214:78-82.
33. Mateo T., Abu Nabah Y.N., Abu Taha M., Mata M., Cerda-Nicolas M., Proudfoot A.E., Stahl R.A., Issekutz A.C., Cortijo J., Morcillo E.J., Jose P.J., Sanz M.J. Angiotensin II-induced mononuclear leukocyte interactions with arteriolar and venular endothelium are mediated by the release of different CC chemokines. J. Immunol. 2006, 176:5577-5586.
34. Matsushima K., Larsen C.G., DuBois G.C., Oppenheim J.J. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J. Exp. Med. 1989, 169:1485-1490.
35. McAvoy E.F., McDonald B., Parsons S.A., Wong C.H., Landmann R., Kubes P. The role of CD14 in neutrophil recruitment within the liver microcirculation during endotoxemia. J. Immunol. 2011, 186:2592-2601.
36. Mecca A.P., Regenhardt R.W., O'Connor T.E., Joseph J.P., Raizada M.K., Katovich M.J., Sumners C. Cerebroprotection by angiotensin-(1-7) in endothelin-1-induced ischaemic stroke. Exp. Physiol. 2011, 96:1084-1096.
37. Metzger R., Bader M., Ludwig T., Berberich C., Bunnemann B., Ganten D. Expression of the mouse and rat mas proto-oncogene in the brain and peripheral tissues. FEBS Lett. 1995, 357:27-32.
38. Nie W., Yan H., Li S., Zhang Y., Yu F., Zhu W., Fan F., Zhu J. Angiotensin-(1-7) enhances angiotensin II induced phosphorylation of ERK1/2 in mouse bone marrow-derived dendritic cells. Mol. Immunol. 2009, 46:355-361.
39. O'Dea K.P., Wilson M.R., Dokpesi J.O., Wakabayashi K., Tatton L., van Rooijen N., Takata M. Mobilization and margination of bone marrow Gr-1high monocytes during subclinical endotoxemia predisposes the lungs toward acute injury. J. Immunol. 2009, 182:1155-1166.
40. Passos-Silva D.G., Verano-Braga T., Santos R.A. Angiotensin-(1-7): beyond the cardio-renal actions. Clin. Sci. (Lond.) 2013, 124:443-456.
41. Peres Bota D., Lopes Ferreira F., Melot C., Vincent J.L. Body temperature alterations in the critically ill. Intensive Care Med. 2004, 30:811-816.
42. Petnehazy T., Cooper D., Stokes K.Y., Russell J., Wood K.C., Granger D.N. Angiotensin II type 1 receptors and the intestinal microvascular dysfunction induced by ischemia and reperfusion. Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 290:1203-1210.
43. Platten M., Youssef S., Hur E.M., Ho P.P., Han M.H., Lanz T.V., Phillips L.K., Goldstein M.J., Bhat R., Raine C.S., Sobel R.A., Steinman L. Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:14948-14953.
44. Price A., Lockhart J.C., Ferrell W.R., Gsell W., McLean S., Sturrock R.D. Angiotensin II type 1 receptor as a novel therapeutic target in rheumatoid arthritis: in vivo analyses in rodent models of arthritis and ex vivo analyses in human inflammatory synovitis. Arthritis Rheum. 2007, 56:441-447.
45. Puntener U., Booth S.G., Perry V.H., Teeling J.L. Long-term impact of systemic bacterial infection on the cerebral vasculature and microglia. J. Neuroinflammation 2012, 9:146.
46. Qin L., Wu X., Block M.L., Liu Y., Breese G.R., Hong J.S., Knapp D.J., Crews F.T. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 2007, 55:453-462.
47. Quan N., Banks W.A. Brain-immune communication pathways. Brain Behav. Immunol. 2007, 21:727-735.
48. Raison C.L., Capuron L., Miller A.H. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006, 27:24-31.
49. Regenhardt R.W., Desland F., Mecca A.P., Pioquinto D.J., Afzal A., Mocco J., Sumners C. Anti-inflammatory effects of angiotensin-(1-7) in ischemic stroke. Neuropharmacology 2013, 71:154-163.
50. Rodrigues-Machado M.G., Magalhaes G.S., Cardoso J.A., Kangussu L.M., Murari A., Caliari M.V., Oliveira M.L., Cara D.C., Noviello M.L., Marques F.D., Pereira J.M., Lautner R.Q., Santos R.A., Campagnole-Santos M.J. Ave 0991, a nonpeptide mimic of angiotensin-(1-7) effects, attenuates pulmonary remodeling in a model of chronic asthma. Br. J. Pharmacol. 2013, 170:835-846.
51. Rodrigues S.F., Granger D.N. Cerebral microvascular inflammation in DOCA salt-induced hypertension: role of angiotensin II and mitochondrial superoxide. J. Cereb. Blood Flow Metab. 2012, 32:368-375.
52. Rubin L.L., Staddon J.M. The cell biology of the blood-brain barrier. Annu. Rev. Neurosci. 1999, 22:11-28.
53. Santos R.A., Ferreira A.J. Angiotensin-(1-7) and the renin-angiotensin system. Curr. Opin. Nephrol. Hypertens 2007, 16:122-128.
54. Santos R.A., Simoes e Silva A.C., Maric C., Silva D.M., Machado R.P., de Buhr I., Heringer-Walther S., Pinheiro S.V., Lopes M.T., Bader M., Mendes E.P., Lemos V.S., Campagnole-Santos M.J., Schultheiss H.P., Speth R., Walther T. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:8258-8263.
55. Silveira K.D., Coelho F.M., Vieira A.T., Barroso L.C., Queiroz-Junior C.M., Costa V.V., Sousa L.F., Oliveira M.L., Bader M., Silva T.A., Santos R.A., Silva A.C., Teixeira M.M. Mechanisms of the anti-inflammatory actions of the angiotensin type 1 receptor antagonist losartan in experimental models of arthritis. Peptides 2013, 46:53-63.
56. Skelly D.T., Hennessy E., Dansereau M.A., Cunningham C. A systematic analysis of the peripheral and CNS effects of systemic LPS, IL-1Beta, TNF-alpha and IL-6 challenges in C57BL/6 mice. PLoS One 2013, 8:e69123.
57. Souza L.L., Costa-Neto C.M. Angiotensin-(1-7) decreases LPS-induced inflammatory response in macrophages. J. Cell Physiol. 2012, 227:2117-2122.
58. Souza L.L., Duchene J., Todiras M., Azevedo L.C., Costa-Neto C.M., Alenina N., Santos R.A., Bader M. Receptor mas protects mice against hypothermia and mortality induced by endotoxemia. Shock 2014, 41:331-336.
59. Sukumaran V., Veeraveedu P.T., Gurusamy N., Yamaguchi K., Lakshmanan A.P., Ma M., Suzuki K., Kodama M., Watanabe K. Cardioprotective effects of telmisartan against heart failure in rats induced by experimental autoimmune myocarditis through the modulation of angiotensin-converting enzyme-2/angiotensin 1-7/mas receptor axis. Int. J. Biol. Sci. 2011, 7:1077-1092.
60. Teeling J.L., Cunningham C., Newman T.A., Perry V.H. The effect of non-steroidal anti-inflammatory agents on behavioural changes and cytokine production following systemic inflammation: implications for a role of COX-1. Brain Behav. Immunol. 2010, 24:409-419.
61. Thompson H.L., Matsushima K. Human polymorphonuclear leucocytes stimulated by tumour necrosis factor-alpha show increased adherence to extracellular matrix proteins which is mediated via the CD11b/18 complex. Clin. Exp. Immunol. 1992, 90:280-285.
62. Tipnis S.R., Hooper N.M., Hyde R., Karran E., Christie G., Turner A.J. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J. Biol. Chem. 2000, 275(33):238-33243.
63. Verlohren S., Muller D.N., Luft F.C., Dechend R. Immunology in hypertension, preeclampsia, and target-organ damage. Hypertension 2009, 54:439-443.
64. Villar A.J., Pedersen R.A. Parental imprinting of the mas protooncogene in mouse. Nat. Genet. 1994, 8:373-379.
65. Vital S.A., Terao S., Nagai M., Granger D.N. Mechanisms underlying the cerebral microvascular responses to angiotensin II-induced hypertension. Microcirculation 2010, 17:641-649.
66. Vlach K.D., Boles J.W., Stiles B.G. Telemetric evaluation of body temperature and physical activity as predictors of mortality in a murine model of staphylococcal enterotoxic shock. Comp. Med. 2000, 50:160-166.
67. Walther T., Balschun D., Voigt J.P., Fink H., Zuschratter W., Birchmeier C., Ganten D., Bader M. Sustained long term potentiation and anxiety in mice lacking the mas protooncogene. J. Biol. Chem. 1998, 273:11867-11873.
68. Wosten-van Asperen R.M., Lutter R., Specht P.A., Moll G.N., van Woensel J.B., van der Loos C.M., van Goor H., Kamilic J., Florquin S., Bos A.P. Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist. J. Pathol. 2011, 225:618-627.
69. Yildirim A., Russell J., Yan L.S., Senchenkova E.Y., Granger D.N. Leukocyte-dependent responses of the microvasculature to chronic angiotensin II exposure. Hypertension 2012, 60:1503-1509.
70. Zhou H., Andonegui G., Wong C.H., Kubes P. Role of endothelial TLR4 for neutrophil recruitment into central nervous system microvessels in systemic inflammation. J. Immunol. 2009, 183:5244-5250.
71. Zhou H., Lapointe B.M., Clark S.R., Zbytnuik L., Kubes P. A requirement for microglial TLR4 in leukocyte recruitment into brain in response to lipopolysaccharide. J. Immunol. 2006, 177:8103-8110.